NATIONWIDE AVAILABILITY THROUGH
PHIL, CAREPOINT, AND ASPN PHARMACIES

How to Use

Words "One giant leap in migraine technology, 3 small steps to use it" on black background
Words "One giant leap in migraine technology, 3 small steps to use it" on black background
Product image of Trudhesa® Precision Olfactory Delivery (POD®) on black background facing left and tilted down

Using Trudhesa® is simple1


See the step-by-step Instructions for Use included with every prescription of Trudhesa.

Product image of an open Trudhesa® Precision Olfactory Delivery (POD®) package showing the POD and vial
"4"

Prime Trudhesa 4 times

"1"

Spray in 1 nostril

"1"

Spray in the other nostril

Watch this brief video to see how straightforward it is to use Trudhesa2,3


Patients should follow complete Instructions for Use, provided with product.

Watch How to Use video. Still representation of an instructional video with a person holding Trudhesa® sitting in a room with words "Be Direct"

TITLE: Be Direct

VOICEOVER: Ok, are you having a migraine attack? Time to be direct. Let’s go. De-box and determine that everything is in good shape. It looks good to me. Next, you install. Just be careful, it can be a little sharp. Well, R is for ready. You ready the POD® by priming it. You press firmly 4 times. This is very important. Looks like it’s ready. Now you engage the POD to the nose, and you press like you’re priming. It’s nice and gentle. Now complete your dose in the other nostril. Last step, T is for toss. Get rid of it, throw it away, you do not need it. You only use it once. That’s it! You have a migraine attack? Be direct. And don’t forget to check out these. Stay tuned for the Important Safety Information. For complete administration information, please see the Instructions for Use sheet that comes in each box of Trudhesa.

How to Prescribe

Actor portrayal of Trudhesa® patient smiling with short hair,  looking to the left
Actor portrayal of Trudhesa® patient smiling with short hair,  looking to the left

References: 1. Trudhesa. Prescribing information. Impel Pharmaceuticals; 2021. 2. Shrewsbury SB, Joekman J, Jeleva M. Patient acceptability of a novel upper nasal delivery system for dihydroergotamine mesylate using the Precision Olfactory Delivery (POD®) device – results from the open-label STOP 301 trial. Poster presented at: American Headache Society Virtual Annual Scientific Meeting, June 3-6, 2021. 3. Data on File. Impel Pharmaceuticals. 2020.